Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists repair liver using stem cells
mouse
Liver stem cells were transplanted into mice with liver failure. (stock photo)
Findings bring us "a step closer" to new therapies
 
For the first time, scientists have managed to repair a severely damaged liver using stem cells grown in the laboratory.

It is hoped their findings will lay the foundations for cell-based therapies in the future, which could offer those with liver failure an alternative to organ transplants.

Scientists from the University of Edinburgh transplanted liver stem cells into mice with liver failure. Over several months, they saw major parts of the liver being regrown from these cells, improving its structure and function.

It is the first time researchers have been able to repair the liver to this extent. If the same effect can be demonstrated with human cells this could be a useful treatment for liver failure.

"Revealing the therapeutic potential of these liver stem cells brings us a step closer to developing stem cell based treatments for patients with liver disease," said Professor Stuart Forbes, from the university's Medical Research Council Centre for Regenerative Medicine.

"It will be some time before we can turn this into reality as we will first need to test our approach using human cells. This is much needed as liver disease is a very common cause of death and disability for patients in the UK and the rest of the world.’"

Long-term, the team are hoping to find a way of using medicines to stimulate the patient's own stem cells to repair the damage.

Although the liver has a great capacity to repair itself, conditions such as cirrhosis and liver failure make this impossible.

Hepatocytes within the liver make proteins and break down toxins. They have been used for transplantation before but their use is limited by the fact that they don't grow well under lab conditions.

This can be overcome with liver stem cells as they can be grown in these conditions and can change into hepatocytes and other types of liver cell.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.